Header Logo

Connection

Kalipada Pahan to Humans

This is a "connection" page, showing publications Kalipada Pahan has written about Humans.
Connection Strength

2.146
  1. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor a. Cells. 2023 Dec 08; 12(24).
    View in: PubMed
    Score: 0.052
  2. Induction of IL-2 by interleukin-12 p40 homodimer and IL-12, but not IL-23, in microglia and macrophages: Implications for multiple sclerosis. Cytokine. 2024 Feb; 174:156457.
    View in: PubMed
    Score: 0.052
  3. Suppression of Experimental Autoimmune Encephalomyelitis in Mice by ?-Hydroxy ?-Methylbutyrate, a Body-Building Supplement in Humans. J Immunol. 2023 07 15; 211(2):187-198.
    View in: PubMed
    Score: 0.050
  4. Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19. J Immunol. 2023 06 15; 210(12):1938-1949.
    View in: PubMed
    Score: 0.050
  5. Upregulation of DJ-1 in Dopaminergic Neurons by a Physically-Modified Saline: Implications for Parkinson's Disease. Int J Mol Sci. 2023 Feb 28; 24(5).
    View in: PubMed
    Score: 0.049
  6. Treadmill workout activates PPARa in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer's disease. Brain Behav Immun. 2023 03; 109:204-218.
    View in: PubMed
    Score: 0.049
  7. Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer. Cells. 2022 01 13; 11(2).
    View in: PubMed
    Score: 0.045
  8. Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses. J Neuroimmune Pharmacol. 2021 12; 16(4):743-755.
    View in: PubMed
    Score: 0.045
  9. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses. J Immunol. 2021 11 15; 207(10):2521-2533.
    View in: PubMed
    Score: 0.045
  10. Selective targeting of the TLR2/MyD88/NF-?B pathway reduces a-synuclein spreading in vitro and in vivo. Nat Commun. 2021 09 10; 12(1):5382.
    View in: PubMed
    Score: 0.044
  11. Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate. Neurobiol Dis. 2021 06; 153:105318.
    View in: PubMed
    Score: 0.043
  12. Is COVID-19 Gender-sensitive? J Neuroimmune Pharmacol. 2021 03; 16(1):38-47.
    View in: PubMed
    Score: 0.042
  13. Oleamide, a Sleep-Inducing Supplement, Upregulates Doublecortin in Hippocampal Progenitor Cells via PPARa. J Alzheimers Dis. 2021; 84(4):1747-1762.
    View in: PubMed
    Score: 0.042
  14. IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12R?1 internalization and suppress EAE. Proc Natl Acad Sci U S A. 2020 09 01; 117(35):21557-21567.
    View in: PubMed
    Score: 0.041
  15. Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? J Neuroimmune Pharmacol. 2020 06; 15(2):174-180.
    View in: PubMed
    Score: 0.041
  16. PPARa serves as a new receptor of aspirin for neuroprotection. J Neurosci Res. 2020 04; 98(4):626-631.
    View in: PubMed
    Score: 0.039
  17. A Broad Application of CRISPR Cas9 in Infectious, Inflammatory and Neurodegenerative Diseases. J Neuroimmune Pharmacol. 2019 12; 14(4):534-536.
    View in: PubMed
    Score: 0.039
  18. Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF. J Neuroimmune Pharmacol. 2019 09; 14(3):503-518.
    View in: PubMed
    Score: 0.038
  19. PPARa Between Aspirin and Plaque Clearance. J Alzheimers Dis. 2019; 71(2):389-397.
    View in: PubMed
    Score: 0.037
  20. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology. J Clin Invest. 2018 10 01; 128(10):4297-4312.
    View in: PubMed
    Score: 0.036
  21. Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-?. Proc Natl Acad Sci U S A. 2017 10 24; 114(43):11482-11487.
    View in: PubMed
    Score: 0.034
  22. Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders. Orphanet J Rare Dis. 2017 06 17; 12(1):113.
    View in: PubMed
    Score: 0.033
  23. Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Enriches Regulatory T Cells via STAT6-Mediated Upregulation of TGF-?. J Immunol. 2016 10 15; 197(8):3099-3110.
    View in: PubMed
    Score: 0.031
  24. Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease. J Biol Chem. 2016 07 15; 291(29):15267-81.
    View in: PubMed
    Score: 0.031
  25. PPARa in lysosomal biogenesis: A perspective. Pharmacol Res. 2016 Jan; 103:144-8.
    View in: PubMed
    Score: 0.030
  26. Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes. Neurochem Res. 2015 Nov; 40(11):2333-47.
    View in: PubMed
    Score: 0.029
  27. HMG-CoA Reductase Inhibitors Bind to PPARa to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice. Cell Metab. 2015 Aug 04; 22(2):253-65.
    View in: PubMed
    Score: 0.029
  28. Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21rac and Protect Memory and Learning in an Animal Model of Alzheimer's Disease. PLoS One. 2015; 10(6):e0130398.
    View in: PubMed
    Score: 0.029
  29. Activation of peroxisome proliferator-activated receptor a stimulates ADAM10-mediated proteolysis of APP. Proc Natl Acad Sci U S A. 2015 Jul 07; 112(27):8445-50.
    View in: PubMed
    Score: 0.029
  30. Activation of peroxisome proliferator-activated receptor a induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders. J Biol Chem. 2015 Apr 17; 290(16):10309-24.
    View in: PubMed
    Score: 0.028
  31. PPARa signaling in the hippocampus: crosstalk between fat and memory. J Neuroimmune Pharmacol. 2015 Mar; 10(1):30-4.
    View in: PubMed
    Score: 0.028
  32. Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(2):385-402.
    View in: PubMed
    Score: 0.028
  33. A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease. PLoS One. 2014; 9(8):e103606.
    View in: PubMed
    Score: 0.027
  34. Enhancement of morphological plasticity in hippocampal neurons by a physically modified saline via phosphatidylinositol-3 kinase. PLoS One. 2014; 9(7):e101883.
    View in: PubMed
    Score: 0.027
  35. Interleukin-12 (IL-12), but not IL-23, induces the expression of IL-7 in microglia and macrophages: implications for multiple sclerosis. Immunology. 2014 Apr; 141(4):549-63.
    View in: PubMed
    Score: 0.027
  36. Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis. J Biol Chem. 2013 Jun 21; 288(25):18533-45.
    View in: PubMed
    Score: 0.025
  37. Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders. J Neuroimmune Pharmacol. 2013 Jun; 8(3):739-55.
    View in: PubMed
    Score: 0.025
  38. Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapy. J Biol Chem. 2013 Mar 22; 288(12):8299-8312.
    View in: PubMed
    Score: 0.025
  39. Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor a: implications for late infantile Batten disease therapy. J Biol Chem. 2012 Nov 09; 287(46):38922-35.
    View in: PubMed
    Score: 0.024
  40. Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-?. J Biol Chem. 2012 Oct 05; 287(41):34134-48.
    View in: PubMed
    Score: 0.024
  41. Suppression of nuclear factor-?B activation and inflammation in microglia by physically modified saline. J Biol Chem. 2012 Aug 24; 287(35):29529-42.
    View in: PubMed
    Score: 0.023
  42. Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease. PLoS One. 2012; 7(6):e38113.
    View in: PubMed
    Score: 0.023
  43. Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense. J Immunol. 2012 Jul 15; 189(2):1002-13.
    View in: PubMed
    Score: 0.023
  44. Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders. J Biol Chem. 2012 Aug 03; 287(32):27189-203.
    View in: PubMed
    Score: 0.023
  45. Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor ?. Neurochem Res. 2012 Aug; 37(8):1718-29.
    View in: PubMed
    Score: 0.023
  46. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J Neuroimmune Pharmacol. 2012 Jun; 7(2):424-35.
    View in: PubMed
    Score: 0.022
  47. Immunomodulation of experimental allergic encephalomyelitis by cinnamon metabolite sodium benzoate. Immunopharmacol Immunotoxicol. 2011 Dec; 33(4):586-93.
    View in: PubMed
    Score: 0.021
  48. Prospects of statins in Parkinson disease. Neuroscientist. 2011 Jun; 17(3):244-55.
    View in: PubMed
    Score: 0.021
  49. Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease. J Neurosci. 2010 Sep 22; 30(38):12676-89.
    View in: PubMed
    Score: 0.021
  50. Sphingolipids in multiple sclerosis. Neuromolecular Med. 2010 Dec; 12(4):351-61.
    View in: PubMed
    Score: 0.020
  51. Neuroimmune pharmacological control of EAE. J Neuroimmune Pharmacol. 2010 Jun; 5(2):165-7.
    View in: PubMed
    Score: 0.020
  52. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease. J Neurosci. 2009 Oct 28; 29(43):13543-56.
    View in: PubMed
    Score: 0.020
  53. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol. 2009 Nov 01; 183(9):5917-27.
    View in: PubMed
    Score: 0.019
  54. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci. 2009 Mar 15; 278(1-2):5-15.
    View in: PubMed
    Score: 0.018
  55. Gemfibrozil, stretching arms beyond lipid lowering. Immunopharmacol Immunotoxicol. 2009; 31(3):339-51.
    View in: PubMed
    Score: 0.018
  56. Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70. Immunology. 2009 Jul; 127(3):312-25.
    View in: PubMed
    Score: 0.018
  57. Role of cytokine p40 family in multiple sclerosis. Minerva Med. 2008 Apr; 99(2):105-18.
    View in: PubMed
    Score: 0.017
  58. MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J Immunol. 2007 Nov 15; 179(10):7101-9.
    View in: PubMed
    Score: 0.017
  59. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A. 2007 Nov 20; 104(47):18754-9.
    View in: PubMed
    Score: 0.017
  60. A simplified method for isolating highly purified neurons, oligodendrocytes, astrocytes, and microglia from the same human fetal brain tissue. Neurochem Res. 2007 Dec; 32(12):2015-22.
    View in: PubMed
    Score: 0.016
  61. Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia. Free Radic Biol Med. 2007 Jun 15; 42(12):1866-78.
    View in: PubMed
    Score: 0.016
  62. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J Neuroimmune Pharmacol. 2007 Jun; 2(2):184-93.
    View in: PubMed
    Score: 0.016
  63. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem Int. 2006 Jul; 49(2):154-63.
    View in: PubMed
    Score: 0.015
  64. Lipid-lowering drugs. Cell Mol Life Sci. 2006 May; 63(10):1165-78.
    View in: PubMed
    Score: 0.015
  65. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal. 2006 May-Jun; 8(5-6):929-47.
    View in: PubMed
    Score: 0.015
  66. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 2006 Apr; 13(4):539-50.
    View in: PubMed
    Score: 0.015
  67. Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes. Free Radic Biol Med. 2005 Sep 15; 39(6):823-31.
    View in: PubMed
    Score: 0.015
  68. Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes. Free Radic Biol Med. 2005 Mar 01; 38(5):655-64.
    View in: PubMed
    Score: 0.014
  69. Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J Neurosci. 2004 Oct 27; 24(43):9531-40.
    View in: PubMed
    Score: 0.014
  70. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem. 2004 Dec 03; 279(49):51451-9.
    View in: PubMed
    Score: 0.014
  71. Role of protein kinase R in double-stranded RNA-induced expression of nitric oxide synthase in human astroglia. FEBS Lett. 2004 Apr 09; 563(1-3):223-8.
    View in: PubMed
    Score: 0.013
  72. Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J Neurochem. 2003 Sep; 86(5):1057-71.
    View in: PubMed
    Score: 0.013
  73. Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J Biol Chem. 2002 Oct 18; 277(42):39312-9.
    View in: PubMed
    Score: 0.012
  74. Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem. 2001 Nov 30; 276(48):44527-33.
    View in: PubMed
    Score: 0.011
  75. Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes. J Neurochem. 2000 Jun; 74(6):2288-95.
    View in: PubMed
    Score: 0.010
  76. Expression of a constitutively active form of phosphatidylinositol 3-kinase inhibits the induction of nitric oxide synthase in human astrocytes. FEBS Lett. 2000 Apr 28; 472(2-3):203-7.
    View in: PubMed
    Score: 0.010
  77. Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide. J Neurochem. 1999 Aug; 73(2):513-20.
    View in: PubMed
    Score: 0.010
  78. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease. Neurobiol Dis. 2020 02; 135:104352.
    View in: PubMed
    Score: 0.009
  79. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest. 1997 Dec 01; 100(11):2671-9.
    View in: PubMed
    Score: 0.009
  80. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata. J Lipid Res. 1996 May; 37(5):1137-43.
    View in: PubMed
    Score: 0.008
  81. Epoxide hydrolase in human and rat peroxisomes: implication for disorders of peroxisomal biogenesis. J Lipid Res. 1996 Jan; 37(1):159-67.
    View in: PubMed
    Score: 0.007
  82. Ketoconazole and other imidazole derivatives are potent inhibitors of peroxisomal phytanic acid alpha-oxidation. FEBS Lett. 1995 Dec 18; 377(2):213-6.
    View in: PubMed
    Score: 0.007
  83. Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes. J Lipid Res. 1995 May; 36(5):986-97.
    View in: PubMed
    Score: 0.007
  84. Intraorganellar localization of CoASH-independent phytanic acid oxidation in human liver peroxisomes. FEBS Lett. 1993 Oct 25; 333(1-2):154-8.
    View in: PubMed
    Score: 0.006
  85. Identification of phytanoyl-CoA ligase as a distinct acyl-CoA ligase in peroxisomes from cultured human skin fibroblasts. FEBS Lett. 1993 May 10; 322(2):101-4.
    View in: PubMed
    Score: 0.006
  86. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy. FEBS Lett. 1998 Apr 24; 426(3):342-6.
    View in: PubMed
    Score: 0.002
  87. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):2961-6.
    View in: PubMed
    Score: 0.002
  88. Late-onset generalized disorder of peroxisomes. Neurology. 1996 Mar; 46(3):829-31.
    View in: PubMed
    Score: 0.002
  89. Nitric oxide regulates peroxisomal enzyme activities. Eur J Clin Chem Clin Biochem. 1995 Nov; 33(11):763-74.
    View in: PubMed
    Score: 0.002
  90. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes. J Lipid Res. 1993 Oct; 34(10):1755-64.
    View in: PubMed
    Score: 0.002
  91. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz. J Biol Chem. 1993 May 15; 268(14):9972-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.